Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsScientists investigated the use of elotuzumab, pomalidomide, and dexamethasone as salvage therapy prior to and maintenance after second autologous hematopoietic cell transplant for relapsed multiple myeloma.
[Transplantation And Cellular Therapy]
Home Newsletters Hematopoiesis News Continuous Elotuzumab, Pomalidomide and Dexamethasone Maintenance Following Second Autologous Transplant for Multiple...
